Contribution of red wine consumption to human health protection

Molecules

Volumn 23, Issue 7, 2018, Pages

  Snopek, Lukas ^a   Mlcek, Jiri ^a   Sochorova, Lenka ^b   Baron, Mojmir ^b   Hlavacova, Irena ^a   Jurikova, Tunde ^c   Kizek, Rene ^d   Sedlackova, Eva ^a   Sochor, Jiri ^b  

^a TOMAS BATA UNIVERSITY IN ZLIN   (Czech Republic)

^b MENDEL UNIVERSITY IN BRNO   (Czech Republic)

^c Constantine the Philosopher University in Nitra ^*  (Slovakia)

^d UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

Alcohol; Antioxidants; Health; Human; Phenolic compounds; Red wine

Indexed keywords

ANTIOXIDANT; PROTECTIVE AGENT;

CHEMISTRY; DRINKING BEHAVIOR; HEALTH; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); WINE;

ALCOHOL DRINKING; ANTIOXIDANTS; HEALTH; HUMANS; PROTECTIVE AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WINE;

EID: 85050484534     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules23071684     Document Type: Article

References (88)

1. Lukacs, P. Inventing Wine: A New History of One of the World’s Most Ancient Pleasures; WW Norton & Company: New York, NY, USA, 2012; ISBN 978-0-393-34707-4.
2. Snopek, L.; Mlček, J.; Fic, V.; Hlaváčová, I.; Škrovánková, S.; Fišera, M.; Velichová, H.; Ondrášová, M. Interaction of polyphenols and wine antioxidants with its Sulfur dioxide preservative. Potravin. Slovak J. Food Sci. 2018, 12, 180–185. [CrossRef]
3. Teissedre, P.L.; Stockley, C.; Boban, M.; Ruf, J.C.; Alba, M.O.; Gambert, P.; Flesh, M. The effects of wine consumption on cardiovascular disease and associated risk factors: A narrative review. OENO ONE 2018, 52, 67–79. [CrossRef]
4. Klatsky, A.L. Alcohol and cardiovascular diseases. Expert Rev. Cardiovasc. Ther. 2009, 7, 499–506. [CrossRef] [PubMed]
5. Cavallini, G.; Straniero, S.; Donati, A.; Bergamini, E. Resveratrol requires red wine polyphenols for optimum antioxidant activity. J. Nutr. Health Aging 2016, 20, 540–545. [CrossRef] [PubMed]
6. Singleton, V.L.; Rossi, J.A. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am. J. Enol. Vitic. 1965, 16, 144–158.
7. Del Pino-García, R.; González-SanJosé, M.L.; Rivero-Pérez, M.D.; García-Lomillo, J.; Muæiz, P. The effects of heat treatment on the phenolic composition and antioxidant capacity of red wine pomace seasonings. Food Chem. 2017, 221, 1723–1732. [CrossRef] [PubMed]
8. Kim, J.H.; Auger, C.; Kurita, I.; Anselm, E.; Rivoarilala, L.O.; Lee, H.J.; Schini-Kerth, V.B. Aronia melanocarpa juice, a rich source of polyphenols, induces endothelium-dependent relaxations in porcine coronary arteries via the redox-sensitive activation of endothelial nitric oxide synthase. Nitric Oxide-Biol. Chem. 2013, 35, 54–64. [CrossRef] [PubMed]
9. Schini-Kerth, V.B.; Auger, C.; Étienne-Selloum, N.; Chataigneau, T. Polyphenol-Induced Endothelium-Dependent Relaxations: Role of NO and EDHF. Cardiovasc. Pharmacol. Endothel. Control 2010, 60, 133–175. [CrossRef]
10. Qureshi, S.A.; Lund, A.C.; Veierød, M.B.; Carlsen, M.H.; Blomhoff, R.; Andersen, L.F.; Ursin, G. Food items contributing most to variation in antioxidant intake; a cross-sectional study among Norwegian women. BMC Public Health 2014, 14. [CrossRef] [PubMed]
11. Tomé-Carneiro, J.; Gonzálvez, M.; Larrosa, M.; Yáæez-Gascón, M.J.; García-Almagro, F.J.; Ruiz-Ros, J.A.; Espín, J.C. Resveratrol in primary and secondary prevention of cardiovascular disease: A dietary and clinical perspective. Ann. N. Y. Acad. Sci. 2013, 1290, 37–51. [CrossRef] [PubMed]
12. Tomé-Carneiro, J.; Larrosa, M.; González-Sarrías, A.; Tomas-Barberan, F.; Teresa Garcia-Conesa, M.; Carlos Espin, J. Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence. Curr. Pharm. Des. 2013, 19, 6064–6093. [CrossRef] [PubMed]
13. Montsko, G.; Ohmacht, R.; Mark, L. trans-Resveratrol and trans-Piceid Content of Hungarian Wines. Chromatographia 2010, 71, 121–124. [CrossRef]
14. Pandey, K.B.; Rizvi, S.I. Anti-oxidative action of resveratrol: Implications for human health. Arab. J. Chem. 2011, 4, 293–298. [CrossRef]
15. Peng, X.L.; Qu, W.; Wang, L.Z.; Huang, B.Q.; Ying, C.J.; Sun, X.F.; Hao, L.P. Resveratrol Ameliorates High Glucose and High-Fat/Sucrose Diet-Induced Vascular Hyperpermeability Involving Cav-1/eNOS Regulation. PLoS ONE 2014, 9, e113716. [CrossRef] [PubMed]
16. Oh, W.Y.; Shahidi, F. Antioxidant activity of resveratrol ester derivatives in food and biological model systems. Food Chem. 2018, 261, 267–273. [CrossRef] [PubMed]
17. Das, J.; Pany, S.; Majhi, A. Chemical modifications of resveratrol for improved protein kinase C alpha activity. Bioorgan. Med. Chem. 2011, 19, 5321–5333. [CrossRef] [PubMed]
18. Mannari, C.; Bertelli, A.A.E.; Stiaccini, G.; Giovannini, L. Wine, sirtuins and nephroprotection: Not only resveratrol. Med. Hypotheses 2010, 75, 636–638. [CrossRef] [PubMed]
19. Ghanim, H.; Sia, C.L.; Abuaysheh, S.; Korzeniewski, K.; Patnaik, P.; Marumganti, A.; Dandona, P. An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J. Clin. Endocrinol. Metab. 2010, 95, E1–E8. [CrossRef] [PubMed]
20. Rahman, M.M.; Bak, I.; Das, D.K. Effectiveness of Resveratrol against Cardiovascular Disease. Mini-Rev. Org. Chem. 2010, 7, 256–261. [CrossRef]
21. Romain, C.; Gaillet, S.; Carillon, J.; Vidé, J.; Ramos, J.; Izard, J.C.; Rouanet, J.M. Vineatrol and Cardiovascular Disease: Beneficial Effects of a Vine-Shoot Phenolic Extract in a Hamster Atherosclerosis Model. J. Agric. Food Chem. 2012, 60, 11029–11036. [CrossRef] [PubMed]
22. Mokni, M.; Hamlaoui, S.; Karkouch, I.; Amri, M.; Marzouki, L.; Limam, F.; Aouani, E. Resveratrol Provides Cardioprotection after Ischemia/reperfusion Injury via Modulation of Antioxidant Enzyme Activities. Iran. J. Pharm. Res. 2013, 12, 867–875. [PubMed]
23. Ghanim, H.; Sia, C.L.; Korzeniewski, K.; Lohano, T.; Abuaysheh, S.; Marumganti, A.; Dandona, P. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high carbohydrate meal. J. Clin. Endocrinol. Metab. 2011, 96, 1409–1414. [CrossRef] [PubMed]
24. Brasnyó, P.; Molnár, G.A.; Mohás, M.; Markó, L.; Laczy, B.; Cseh, J.; Mészáros, L.G. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 2011, 106, 383–389. [CrossRef] [PubMed]
25. Timmers, S.; Konings, E.; Bilet, L.; Houtkooper, R.H.; van de Weijer, T.; Goossens, G.H.; Moonen-Kornips, E. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011, 14, 612–622. [CrossRef] [PubMed]
26. Bo, S.; Ciccone, G.; Castiglione, A.; Gambino, R.; De Michieli, F.; Villois, P.; Cassader, M. Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo controlled, cross-over trial. Curr. Med. Chem. 2013, 20, 1323–1331. [CrossRef] [PubMed]
27. Bhatt, J.K.; Thomas, S.; Nanjan, M.J. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr. Res. 2012, 32, 537–541. [CrossRef]
28. Knop, F.K.; Konings, E.; Timmers, S.; Schrauwen, P.; Holst, J.J.; Blaak, E.E. Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects. Diabet. Med. 2013, 30, 1214–1218. [CrossRef] [PubMed]
29. Bashmakov, Y.K.; Assaad-Khalil, S.H.; Abou Seif, M.; Udumyan, R.; Megallaa, M.; Rohoma, K.H.; Petyaev, I.M. Resveratrol promotes foot ulcer size reduction in type 2 diabetes patients. ISRN Endocrinol. 2014, 2014, 816307. [CrossRef] [PubMed]
30. Dos Santos, K.C.; Braga, C.P.; Barbanera, P.O.; Seiva, F.R.F.; Junior, A.F.; Fernandes, A.A.H. Cardiac Energy Metabolism and Oxidative Stress Biomarkers in Diabetic Rat Treated with Resveratrol. PLoS ONE 2014, 9, e102775. [CrossRef] [PubMed]
31. Semba, R.D.; Ferrucci, L.; Bartali, B.; Urpí-Sarda, M.; Zamora-Ros, R.; Sun, K.; Andres-Lacueva, C. Resveratrol Levels and All-Cause Mortality in Older Community-Dwelling Adults. JAMA Int. Med. 2014, 174, 1077–1084. [CrossRef] [PubMed]
32. Menet, M.C.; Marchal, J.; Dal-Pan, A.; Taghi, M.; Nivet-Antoine, V.; Dargère, D.; Cottart, C.H. Resveratrol Metabolism in a Non-Human Primate, the Grey Mouse Lemur (Microcebus murinus), Using Ultra-High-Performance Liquid Chromatography–Quadrupole Time of Flight. PLoS ONE 2014, 9, e91932. [CrossRef] [PubMed]
33. 2-induced apoptosis. J. Ethnopharmacol. 2014, 153, 552–560. [CrossRef] [PubMed]
34. Quintieri, A.M.; Baldino, N.; Filice, E.; Seta, L.; Vitetti, A.; Tota, B.; Angelone, T. Malvidin, a red wine polyphenol, modulates mammalian myocardial and coronary performance and protects the heart against ischemia/reperfusion injury. J. Nutr. Biochem. 2013, 24, 1221–1231. [CrossRef] [PubMed]
35. Bognar, E.; Sarszegi, Z.; Szabo, A.; Debreceni, B.; Kalman, N.; Tucsek, Z.; Gallyas, F., Jr. Antioxidant and Anti-Inflammatory Effects in RAW264.7 Macrophages of Malvidin, a Major Red Wine Polyphenol. PLoS ONE 2013, 8, e65355. [CrossRef]
36. Gu, L.; Kelm, M.A.; Hammerstone, J.F.; Beecher, G.; Holden, J.; Haytowitz, D.; Prior, R.L. Concentrations of Proanthocyanidins in Common Foods and Estimations of Normal Consumption. J. Nutr. 2004, 134, 613–617. [CrossRef] [PubMed]
37. Corder, R.; Mullen, W.; Khan, N.Q.; Marks, S.C.; Wood, E.G.; Carrier, M.J.; Crozier, A. Oenology: Red wine procyanidins and vascular health. Nature 2006, 444, 566. [CrossRef] [PubMed]
38. Panchal, S.K.; Brown, L. Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats. Eur. J. Nutr. 2013, 52, 397–408. [CrossRef] [PubMed]
39. Rossi, M.; Praud, D.; Compagnoni, M.M.; Bellocco, R.; Serafini, M.; Parpinel, M.; Tavani, A. Dietary non-enzymatic antioxidant capacity and the risk of myocardial infarction: A case-control study in Italy. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 1246–1251. [CrossRef] [PubMed]
40. Elmadhun, N.Y.; Sabe, A.A.; Lassaletta, A.D.; Sellke, F.W. Ethanol promotes new vessel growth in remote nonischemic myocardium. J. Surg. Res. 2015, 193, 536–542. [CrossRef] [PubMed]
41. Platiša, M.M.; Gal, V.; Nestorović, Z.; Gojković-Bukarica, L. Quantification of the acute effect of a low dose of red wine by nonlinear measures of RR and QT interval series in healthy subjects. Comput. Biol. Med. 2014, 53, 291–296. [CrossRef] [PubMed]
42. Matsumoto, C.; Miedema, M.D.; Ofman, P.; Gaziano, J.M.; Sesso, H.D. An Expanding Knowledge of the Mechanisms and Effects of Alcohol Consumption on Cardiovascular Disease. J. Cardiopulm. Rehabil. Prev. 2014, 34, 159–171. [CrossRef] [PubMed]
43. Toth, A.; Sandor, B.; Papp, J.; Rabai, M.; Botor, D.; Horvath, Z.; Czopf, L. Moderate red wine consumption improves hemorheological parameters in healthy volunteers. Clin. Hemorheol. Microcirc. 2014, 56, 13–23. [CrossRef] [PubMed]
44. Elmadhun, N.Y.; Sabe, A.A.; Lassaletta, A.D.; Sellke, F.W. Alcohol Consumption Mitigates Apoptosis and Mammalian Target of Rapamycin Signaling in Myocardium. J. Am. Coll. Surg. 2014, 218, 1175–1181. [CrossRef] [PubMed]
45. Droste, D.W.; Iliescu, C.; Vaillant, M.; Gantenbein, M.; De Bremaeker, N.; Lieunard, C.; Gilson, G. A daily glass of red wine associated with lifestyle changes independently improves blood lipids in patients with carotid arteriosclerosis: Results from a randomized controlled trial. Nutr. J. 2013, 12. [CrossRef] [PubMed]
46. Chu, L.M.; Lassaletta, A.D.; Robich, M.P.; Liu, Y.; Burgess, T.; Laham, R.J.; Sellke, F.W. Effects of Red Wine and Vodka on Collateral-Dependent Perfusion and Cardiovascular Function in Hypercholesterolemic Swine. Circulation 2012, 126, S65–S72. [CrossRef] [PubMed]
47. Yoo, Y.J.; Saliba, A.J.; MacDonald, J.B.; Prenzler, P.D.; Ryan, D. A cross-cultural study of wine consumers with respect to health benefits of wine. Food Qual. Prefer. 2013, 28, 531–538. [CrossRef]
48. Djoussé, L.; Lee, I.-M.; Buring, J.E.; Gaziano, J.M. Alcohol Consumption and Risk of Cardiovascular Disease and Mortality in Women: Potential Mediating Mechanisms. Circulation 2009, 120, 237–244. [CrossRef] [PubMed]
49. Gea, A.; Bes-Rastrollo, M.; Toledo, E.; Garcia-Lopez, M.; Beunza, J.J.; Estruch, R.; Martinez-Gonzalez, M.A. Mediterranean alcohol-drinking pattern and mortality in the SUN (Seguimiento Universidad de Navarra) Project: A prospective cohort study. Br. J. Nutr. 2014, 111, 1871–1880. [CrossRef] [PubMed]
50. O’Keefe, J.H.; Bhatti, S.K.; Bajwa, A.; DiNicolantonio, J.J.; Lavie, C.J. Alcohol and Cardiovascular Health: The Dose Makes the Poison . . . or the Remedy. Mayo Clin. Proc. 2014, 89, 382–393. [CrossRef] [PubMed]
51. Yamagata, K.; Tagami, M.; Yamori, Y. Dietary polyphenols regulate endothelial function and prevent cardiovascular disease. Nutrition 2015, 31, 28–37. [CrossRef] [PubMed]
52. Sinkiewicz, W.; Weglarz, M.; Chudzinska, M. Wine, alcohol and cardiovascular diseases. Kardiol. Polska 2014, 72, 771–776. [CrossRef] [PubMed]
53. Medina-Inojosa, J.; Jean, N.; Cortes-Bergoderi, M.; Lopez-Jimenez, F. The Hispanic Paradox in Cardiovascular Disease and Total Mortality. Prog. Cardiovasc. Dis. 2014, 57, 286–292. [CrossRef] [PubMed]
54. Vilahur, G.; Badimon, L. Antiplatelet properties of natural products. Vasc. Pharmacol. 2013, 59, 67–75. [CrossRef] [PubMed]
55. Cioni, G.; Boddi, M.; Fatini, C.; Romagnuolo, I.; Casini, A.; Gensini, G.F.; Sofi, F. Peripheral-Arterial Tonometry for Assessing Endothelial Function in Relation to Dietary Habits. J. Investig. Med. 2013, 61, 867–871. [CrossRef] [PubMed]
56. Giacosa, A.; Barale, R.; Bavaresco, L.; Gatenby, P.; Gerbi, V.; Janssens, J.; Morazzoni, P. Cancer prevention in Europe: The Mediterranean diet as a protective choice. Eur. J. Cancer Prev. 2013, 22, 90–95. [CrossRef] [PubMed]
57. Tognon, G.; Lissner, L.; Sæbye, D.; Walker, K.Z.; Heitmann, B.L. The Mediterranean diet in relation to mortality and CVD: A Danish cohort study. Br. J. Nutr. 2014, 111, 151–159. [CrossRef] [PubMed]
58. Stricker, M.D.; Onland-Moret, N.C.; Boer, J.M.A.; Van Der Schouw, Y.T.; Verschuren, W.M.M.; May, A.M.; Beulens, J.W.J. Dietary patterns derived from principal component- and k-means cluster analysis: Long-term association with coronary heart disease and stroke. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 250–256. [CrossRef] [PubMed]
59. Peterson, J.; Dwyer, J.; Adlercreutz, H.; Scalbert, A.; Jacques, P.; McCullough, M.L. Dietary lignans: Physiology and potential for cardiovascular disease risk reduction. Nutr. Rev. 2010, 68, 571–603. [CrossRef] [PubMed]
60. Lin, Y.; Yngve, A.; Lagergren, J.; Lu, Y. A dietary pattern rich in lignans, quercetin and resveratrol decreases the risk of oesophageal cancer. Br. J. Nutr. 2014, 112, 2002–2009. [CrossRef] [PubMed]
61. Bremholm, L.; Funch-Jensen, P.; Eriksen, J.; Hendel, L.; Havelund, T.; Matzen, P. Barrett’s esophagus. Diagnosis, follow-up and treatment. Dan. Med. J. 2012, 59, C4499. [PubMed]
62. Thrift, A.P.; Cook, M.B.; Vaughan, T.L.; Anderson, L.A.; Murray, L.J.; Whiteman, D.C.; Corley, D.A. Alcohol and the Risk of Barrett’s Esophagus: A Pooled Analysis from the International BEACON Consortium. Am. J. Gastroenterol. 2014, 109, 1586–1594. [CrossRef] [PubMed]
63. Thrift, A.P.; Pandeya, N.; Smith, K.J.; Mallitt, K.A.; Green, A.C.; Webb, P.M.; Whiteman, D.C. Lifetime Alcohol Consumption and Risk of Barrett’s Esophagus. Am. J. Gastroenterol. 2011, 106, 1220–1230. [CrossRef] [PubMed]
64. Kasicka-Jonderko, A. Alcohol and the digestive system—Should it always be blamed? Prz. Gastroenterol. 2012, 7, 264–275. [CrossRef]
65. Barstad, B.; Sørensen, T.I.A.; Tjønneland, A.; Johansen, D.; Becker, U.; Andersen, I.B.; Grønbæk, M. Intake of wine, beer and spirits and risk of gastric cancer. Eur. J. Cancer Prev. 2005, 14, 239–243. [CrossRef] [PubMed]
66. Rosen, L.; Rosen, G. Cancer Facts and Figures; American Cancer Society: Atlanta, GA, USA, 2008.
67. Biasi, F.; Deiana, M.; Guina, T.; Gamba, P.; Leonarduzzi, G.; Poli, G. Wine consumption and intestinal redox homeostasis. Redox Biol. 2014, 2, 795–802. [CrossRef] [PubMed]
68. Seeram, N.P.; Aviram, M.; Zhang, Y.; Henning, S.M.; Feng, L.; Dreher, M.; Heber, D. Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J. Agric. Food Chem. 2008, 56, 1415–1422. [CrossRef] [PubMed]
69. CIP expression. Carcinogenesis 2000, 21, 1619–1622. [CrossRef] [PubMed]
70. Bishayee, A.; Politis, T.; Darvesh, A.S. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat. Rev. 2010, 36, 43–53. [CrossRef] [PubMed]
71. Carbó, N.; Costelli, P.; Baccino, F.M.; López-Soriano, F.J.; Argilés, J.M. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem. Biophys. Res. Commun. 1999, 254, 739–743. [CrossRef] [PubMed]
72. Lee, E.S.; Shin, M.O.; Yoon, S.; Moon, J.O. Resveratrol Inhibits Dimethylnitrosamine-Induced Hepatic Fibrosis in Rats. Arch. Pharm. Res. 2010, 33, 925–932. [CrossRef] [PubMed]
73. 4 Hydrolase. Cancer Res. 2010, 70, 9755–9764. [CrossRef] [PubMed]
74. Da Luz, P.L.; Coimbra, S.; Favarato, D.; Albuquerque, C.; Mochiduky, R.I.; Rochitte, C.E.; Laurindo, F.R. Coronary artery plaque burden and calcium scores in healthy men adhering to long-term wine drinking or alcohol abstinence. Braz. J. Med. Biol. Res. 2014, 47, 697–705. [CrossRef]
75. Janega, P.; Klimentová, J.; Barta, A.; Kovácsová, M.; Vranková, S.; Cebová, M.; Pechánová, O. Red wine extract decreases pro-inflammatory markers, nuclear factor-kappa B and inducible NOS, in experimental metabolic syndrome. Food Funct. 2014, 5, 2202–2207. [CrossRef] [PubMed]
76. Dutta, D.; Xu, J.; Dirain, M.L.; Leeuwenburgh, C. Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity. Free Radic. Biol. Med. 2014, 74, 252–262. [CrossRef] [PubMed]
77. Lee, D.H.; Choi, S.S.; Kim, B.B.; Kim, S.Y.; Kang, B.S.; Lee, S.J.; Park, H.J. Effect of alcohol-free red wine concentrates on cholesterol homeostasis: An in vitro and in vivo study. Process Biochem. 2013, 48, 1964–1971. [CrossRef]
78. Karadeniz, M.; Ak ay, Y.D.; Yıldırım, H.K.; Yılmaz, C.; S zmen, E.Y. Effect of Red Wine Consumption on Serum Oxidation and Adiponectin Levels in Overweight and Healthy Individuals. Pol. J. Food Nutr. Sci. 2014, 64, 201–207. [CrossRef]
79. Xiang, L.; Xiao, L.; Wang, Y.; Li, H.; Huang, Z.; He, X. Health benefits of wine: Don’t expect resveratrol too much. Food Chem. 2014, 156, 258–263. [CrossRef] [PubMed]
80. Bresciani, L.; Calani, L.; Bocchi, L.; Delucchi, F.; Savi, M.; Ray, S.; Del Rio, D. Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 408–415. [CrossRef] [PubMed]
81. Chiva-Blanch, G.; Urpi-Sarda, M.; Ros, E.; Valderas-Martinez, P.; Casas, R.; Arranz, S.; Guillén, M.; Lamuela-Raventós, R.M.; Llorach, R.; Andres-Lacueva, C.; et al. Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: A randomized clinical trial. Clin. Nutr. 2013, 32, 200–206. [CrossRef] [PubMed]
82. Blomster, J.I.; Zoungas, S.; Chalmers, J.; Li, Q.; Chow, C.K.; Woodward, M.; Neal, B. The Relationship between Alcohol Consumption and Vascular Complications and Mortality in Individuals with Type 2 Diabetes. Diabetes Care 2014, 37, 1353–1359. [CrossRef] [PubMed]
83. Chiva-Blanch, G.; Urpi-Sarda, M.; Ros, E.; Arranz, S.; Valderas-Martinez, P.; Casas, R.; Estruch, R. Dealcoholized Red Wine Decreases Systolic and Diastolic Blood Pressure and Increases Plasma Nitric Oxide. Circ. Res. 2012, 111, 1065. [CrossRef] [PubMed]
84. Bulut, D.; Jelich, U.; Dacanay-Schwarz, R.; M gge, A. Red Wine Ingestion Prevents Microparticle Formation after a Single High-Fat Meal-A Crossover Study in Healthy Humans. J. Cardiovasc. Pharmacol. 2013, 61, 489–494. [CrossRef] [PubMed]
85. Toth, A.; Papp, J.; Rabai, M.; Kenyeres, P.; Marton, Z.; Kesmarky, G.; Toth, K. The role of hemorheological factors in cardiovascular medicine. Clin. Hemorheol. Microcirc. 2014, 56, 197–204. [CrossRef] [PubMed]
86. Dillenburg, D.R.; Mostarda, C.; Moraes-Silva, I.C.; Ferreira, D.; Bós, D.D.S.G.; Duarte, A.A.M.; Rigatto, K. Resveratrol and grape juice differentially ameliorate cardiovascular autonomic modulation in L-NAME-treated rats. Auton. Neurosci.-Basic Clin. 2013, 179, 9–13. [CrossRef] [PubMed]
87. Levantesi, G.; Marfisi, R.; Mozaffarian, D.; Franzosi, M.G.; Maggioni, A.; Nicolosi, G.L.; Marchioli, R. Wine consumption and risk of cardiovascular events after myocardial infarction: Results from the GISSI-Prevenzione trial. Int. J. Cardiol. 2013, 163, 282–287. [CrossRef] [PubMed]
88. Covas, M.I.; Gambert, P.; Fitó, M.; de la Torre, R. Wine and oxidative stress: Up-to-date evidence of the effects of moderate wine consumption on oxidative damage in humans. Atherosclerosis 2010, 208, 297–304. [CrossRef] [PubMed]